A5057079772- Chemotherapy-induced cardiotoxicity and mitigation
- Cerebrovascular and Carotid Artery Diseases
- Intracranial Aneurysms: Treatment and Complications
- Antiplatelet Therapy and Cardiovascular Diseases
- Mechanical Circulatory Support Devices
- Advanced Breast Cancer Therapies
- Cardiac Structural Anomalies and Repair
- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Traumatic Brain Injury and Neurovascular Disturbances
- Intracerebral and Subarachnoid Hemorrhage Research
- Myasthenia Gravis and Thymoma
- Autoimmune Neurological Disorders and Treatments
- Cerebrospinal fluid and hydrocephalus
- Neurosurgical Procedures and Complications
- Patient Safety and Medication Errors
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Peripheral Artery Disease Management
- Heart Failure Treatment and Management
- Sepsis Diagnosis and Treatment
- Peripheral Neuropathies and Disorders
- Metabolism, Diabetes, and Cancer
OhioHealth
2019-2023
Riverside Methodist Hospital
2019-2023
May Institute
2020
The Ohio State University
2019
Columbus Oncology and Hematology Associates
2019
Abstract Background Nimodipine improves outcomes following aneurysmal subarachnoid hemorrhage (aSAH) and current guidelines suggest that patients with aSAH receive nimodipine for 21 days. Patients no difficulty swallowing will swallow the whole capsules or tablets; otherwise, liquid must be drawn from capsules, tablets need to crushed, commercially available product used facilitate administration through an enteral feeding tube (FT). It is not clear whether these techniques are equivalent....
Background Thrombolytic therapy significantly improves outcomes among patients with acute ischemic stroke. While cancer have dramatically improved, the utilization, safety, and mortality of who receive thrombolytic for stroke are unknown. Methods Using a national database, we identified all hospitalizations requiring between 2003 2015. Patients contraindications to were excluded. Following propensity score matching comorbidity burden, trends in use its effect on in-hospital mortality,...
Abstract Aims Improved cancer survivorship has led to a higher number of anthracycline‐induced cardiomyopathy patients with end‐stage heart failure. We hypothesize that outcomes following continuous‐flow LVAD (CF‐LVAD) implantation in those are comparable other aetiologies cardiomyopathy. Methods and results Using the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) from 2008 2017, we identified who received CF‐LVAD compared them idiopathic dilated (IDM)...
Background Emergent neuroendovascular stenting presents challenges for the utilization of antiplatelet agents. Methods This was a multicenter, retrospective cohort patients who underwent emergent stenting. The primary endpoints were thrombotic and bleeding events in relation to timing administration, route choice intravenous (IV) agent study investigated practice variability utilization. Results Five-hundred seventy screened across 12 sites. Of those, 167 included data analysis. For...
Purpose: The Lean methodology was applied to clinical metrics by a critical care pharmacy team. experiences associated with the development and implementation of their impact on daily workflow are described. Summary: has been introduced into healthcare system as means process improvement, which can eliminate waste through appropriate medication utilization. At OhioHealth Riverside Methodist Hospital, department tasked after health wide Gemba walk initiated. department's team developed...
Critical Care Medicine: January 2020 - Volume 48 Issue 1 p 793 doi: 10.1097/01.ccm.0000648444.23714.c6
Introduction: Anthracycline-induced cardiomyopathy (AC-CM) presenting as end-stage heart failure may require mechanical circulatory support. Hypothesis: We hypothesize that there is no difference in outcomes after LVAD placement those with AC-CM compared to other forms of cardiomyopathy. Methods: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) dataset spanning from 2008 2017 was utilized identify adult patients undergoing continuous flow implantation excluding...